Literature DB >> 7561106

A nonlethal rat parvovirus infection suppresses rat T lymphocyte effector functions.

M D McKisic1, F X Paturzo, D J Gaertner, R O Jacoby, A L Smith.   

Abstract

Inoculation of the UMass strain of rat virus (RV-UMass) into adult immunocompetent rats results in a prolonged subclinical infection that is resolved in 4 to 8 wk. Co-labeling studies, using in situ hybridization (ISH) and immunohistochemistry (IHC), confirmed that RV-UMass was lymphocytotropic and capable of infecting CD4+ and CD8+ T cells as well as B cells. ISH studies also revealed that virus replication was restricted in unstimulated cells but was productive in concanavalin A-stimulated lymphocytes. A corollary of productive infection of lymphocytes was the suppression of lymphocyte functions. Although RV-UMass did not appear to induce phenotypic changes during the course of infection, cells from infected rats had diminished proliferation and cytolytic responses. Both peripheral and mesenteric lymph node cells exhibited only partial recovery of their proliferative and cytolytic capacities one month after infection. Furthermore, RV-UMass-infected tissue culture maintained alloreactive CD4+ T cells in vitro, and a nonlethal infection of this T cell line inhibited Ag- and IL-2-induced proliferation. Because parvoviruses are widespread among laboratory rodents, these findings emphasize the importance of identifying and excluding parvovirus infection in rodents and in cultures of rat T lymphocytes.

Entities:  

Mesh:

Year:  1995        PMID: 7561106

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Persistent rat virus infection in smooth muscle of euthymic and athymic rats.

Authors:  R O Jacoby; E A Johnson; F X Paturzo; L Ball-Goodrich
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  The rat diabetes susceptibility locus Iddm4 and at least one additional gene are required for autoimmune diabetes induced by viral infection.

Authors:  Elizabeth P Blankenhorn; Lucy Rodemich; Cristina Martin-Fernandez; Jean Leif; Dale L Greiner; John P Mordes
Journal:  Diabetes       Date:  2005-04       Impact factor: 9.461

3.  T helper cell-mediated interferon-gamma expression after human parvovirus B19 infection: persisting VP2-specific and transient VP1u-specific activity.

Authors:  R Franssila; J Auramo; S Modrow; M Möbs; C Oker-Blom; P Käpylä; M Söderlund-Venermo; K Hedman
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

4.  Herpes simplex virus type 2 inhibition of Fas ligand expression.

Authors:  S Sieg; Z Yildirim; D Smith; N Kayagaki; H Yagita; Y Huang; D Kaplan
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

5.  Rat parvovirus type 1: the prototype for a new rodent parvovirus serogroup.

Authors:  L J Ball-Goodrich; S E Leland; E A Johnson; F X Paturzo; R O Jacoby
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

6.  Immune responses to the major capsid protein during parvovirus infection of rats.

Authors:  Lisa J Ball-Goodrich; Frank X Paturzo; Elizabeth A Johnson; Krista Steger; Robert O Jacoby
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Temporal induction of immunoregulatory processes coincides with age-dependent resistance to viral-induced type 1 diabetes.

Authors:  Y G Chen; J P Mordes; E P Blankenhorn; H Kashmiri; M L Kaldunski; S Jia; R Geoffrey; X Wang; M J Hessner
Journal:  Genes Immun       Date:  2013-06-06       Impact factor: 2.676

8.  Old enemies, still with us after all these years.

Authors:  Charles B Clifford; Julie Watson
Journal:  ILAR J       Date:  2008

Review 9.  Health Monitoring of Laboratory Rodent Colonies-Talking about (R)evolution.

Authors:  Stephanie Buchheister; André Bleich
Journal:  Animals (Basel)       Date:  2021-05-14       Impact factor: 2.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.